HC Wainwright & Co. Maintains Buy on Adicet Bio, Lowers Price Target to $27

Benzinga Newsdesk www.benzinga.com Neutral 56.6%

Neg 0% Neu 56.6% Pos 0%

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $50 to $27.